Meinian Onehealth Healthcare Holdings Co., Ltd. (002044.SZ)
CNY 5.46
(-0.91%)
CNY 5.46
(-0.91%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 3.48 Billion CNY | 7.95% |
| 2022 | 3.23 Billion CNY | -11.12% |
| 2021 | 3.63 Billion CNY | 96.08% |
| 2020 | 1.85 Billion CNY | -23.27% |
| 2019 | 2.41 Billion CNY | -19.37% |
| 2018 | 2.99 Billion CNY | 1506.53% |
| 2017 | 186.53 Million CNY | 43.02% |
| 2016 | 130.42 Million CNY | 127.4% |
| 2015 | -476.01 Million CNY | -577.14% |
| 2014 | -70.29 Million CNY | 41.64% |
| 2013 | -120.45 Million CNY | 38.88% |
| 2012 | -197.07 Million CNY | -15.87% |
| 2011 | -170.07 Million CNY | 8.71% |
| 2010 | -186.3 Million CNY | 21.19% |
| 2009 | -236.39 Million CNY | -16.97% |
| 2008 | -202.1 Million CNY | -11.49% |
| 2007 | -181.27 Million CNY | -2.6% |
| 2006 | -176.68 Million CNY | 3.75% |
| 2005 | -183.56 Million CNY | -287.66% |
| 2004 | -47.35 Million CNY | 9.69% |
| 2003 | -52.43 Million CNY | -3.94% |
| 2002 | -50.44 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 4.91 Billion CNY | 16.81% |
| 2024 Q3 | 2.35 Billion CNY | -30.5% |
| 2024 Q1 | 4.2 Billion CNY | 20.69% |
| 2023 Q1 | 3.69 Billion CNY | 14.35% |
| 2023 FY | 3.48 Billion CNY | 7.95% |
| 2023 Q2 | 4.14 Billion CNY | 12.24% |
| 2023 Q3 | 4.01 Billion CNY | -3.27% |
| 2023 Q4 | 3.48 Billion CNY | -13.05% |
| 2022 Q4 | 3.23 Billion CNY | -28.26% |
| 2022 Q3 | 4.5 Billion CNY | -5.52% |
| 2022 Q1 | 4.51 Billion CNY | 24.24% |
| 2022 Q2 | 4.76 Billion CNY | 5.54% |
| 2022 FY | 3.23 Billion CNY | -11.12% |
| 2021 Q2 | 5.57 Billion CNY | -2.6% |
| 2021 Q3 | 5.11 Billion CNY | -8.16% |
| 2021 FY | 3.63 Billion CNY | 96.08% |
| 2021 Q4 | 3.63 Billion CNY | -28.95% |
| 2021 Q1 | 5.72 Billion CNY | 208.55% |
| 2020 Q3 | 3.63 Billion CNY | -0.64% |
| 2020 Q4 | 1.85 Billion CNY | -49.02% |
| 2020 Q1 | 3.6 Billion CNY | 49.29% |
| 2020 FY | 1.85 Billion CNY | -23.27% |
| 2020 Q2 | 3.65 Billion CNY | 1.47% |
| 2019 Q4 | 2.41 Billion CNY | -59.11% |
| 2019 FY | 2.41 Billion CNY | -19.37% |
| 2019 Q3 | 5.9 Billion CNY | 13.77% |
| 2019 Q2 | 5.19 Billion CNY | 24.78% |
| 2019 Q1 | 4.16 Billion CNY | 38.9% |
| 2018 Q3 | 3.97 Billion CNY | 17.47% |
| 2018 Q4 | 2.99 Billion CNY | -24.7% |
| 2018 FY | 2.99 Billion CNY | 1506.53% |
| 2018 Q1 | 1.45 Billion CNY | 678.69% |
| 2018 Q2 | 3.38 Billion CNY | 133.24% |
| 2017 Q3 | 1.15 Billion CNY | 65.93% |
| 2017 Q1 | 635.53 Million CNY | 387.28% |
| 2017 FY | 186.53 Million CNY | 43.02% |
| 2017 Q4 | 186.53 Million CNY | -83.88% |
| 2017 Q2 | 697.56 Million CNY | 9.76% |
| 2016 Q3 | 504.18 Million CNY | 85.49% |
| 2016 Q4 | 130.42 Million CNY | -74.13% |
| 2016 Q2 | 271.82 Million CNY | 282.86% |
| 2016 Q1 | -148.65 Million CNY | 68.77% |
| 2016 FY | 130.42 Million CNY | 127.4% |
| 2015 Q1 | -74.93 Million CNY | -6.6% |
| 2015 FY | -476.01 Million CNY | -577.14% |
| 2015 Q3 | -211.19 Million CNY | -1152.17% |
| 2015 Q2 | 20.07 Million CNY | 126.78% |
| 2015 Q4 | -476.01 Million CNY | -125.4% |
| 2014 FY | -70.29 Million CNY | 41.64% |
| 2014 Q4 | -70.29 Million CNY | -1168.13% |
| 2014 Q2 | 71.21 Million CNY | 223.38% |
| 2014 Q3 | 6.58 Million CNY | -90.76% |
| 2014 Q1 | -57.71 Million CNY | 52.08% |
| 2013 Q3 | -121.52 Million CNY | -32.69% |
| 2013 Q2 | -91.58 Million CNY | 50.71% |
| 2013 Q1 | -185.82 Million CNY | 5.71% |
| 2013 FY | -120.45 Million CNY | 38.88% |
| 2013 Q4 | -120.45 Million CNY | 0.88% |
| 2012 FY | -197.07 Million CNY | -15.87% |
| 2012 Q3 | -173.56 Million CNY | -76.93% |
| 2012 Q2 | -98.1 Million CNY | 44.07% |
| 2012 Q1 | -175.41 Million CNY | -3.14% |
| 2012 Q4 | -197.07 Million CNY | -13.54% |
| 2011 FY | -170.07 Million CNY | 8.71% |
| 2011 Q3 | -155.8 Million CNY | -39.46% |
| 2011 Q4 | -170.07 Million CNY | -9.16% |
| 2011 Q2 | -111.71 Million CNY | 29.09% |
| 2011 Q1 | -157.54 Million CNY | 15.44% |
| 2010 Q3 | -198.77 Million CNY | 9.63% |
| 2010 Q2 | -219.96 Million CNY | 11.77% |
| 2010 FY | -186.3 Million CNY | 21.19% |
| 2010 Q1 | -249.31 Million CNY | -5.47% |
| 2010 Q4 | -186.3 Million CNY | 6.27% |
| 2009 Q2 | -209.82 Million CNY | 3.23% |
| 2009 Q3 | -218.79 Million CNY | -4.27% |
| 2009 FY | -236.39 Million CNY | -16.97% |
| 2009 Q4 | -236.39 Million CNY | -8.04% |
| 2009 Q1 | -216.84 Million CNY | -7.3% |
| 2008 Q2 | -182.69 Million CNY | 9.35% |
| 2008 Q3 | -188.69 Million CNY | -3.29% |
| 2008 Q1 | -201.53 Million CNY | -11.18% |
| 2008 Q4 | -202.1 Million CNY | -7.1% |
| 2008 FY | -202.1 Million CNY | -11.49% |
| 2007 Q3 | -201.21 Million CNY | -7.41% |
| 2007 FY | -181.27 Million CNY | -2.6% |
| 2007 Q4 | -181.27 Million CNY | 9.91% |
| 2007 Q1 | -191.45 Million CNY | -8.36% |
| 2007 Q2 | -187.33 Million CNY | 2.15% |
| 2006 Q3 | -170.4 Million CNY | 5.85% |
| 2006 Q2 | -180.99 Million CNY | 0.94% |
| 2006 Q4 | -176.68 Million CNY | -3.69% |
| 2006 FY | -176.68 Million CNY | 3.75% |
| 2006 Q1 | -182.71 Million CNY | 0.47% |
| 2005 Q3 | -198.93 Million CNY | -2.48% |
| 2005 Q2 | -194.11 Million CNY | 0.0% |
| 2005 FY | -183.56 Million CNY | -287.66% |
| 2005 Q4 | -183.56 Million CNY | 7.72% |
| 2004 FY | -47.35 Million CNY | 9.69% |
| 2004 Q4 | -47.35 Million CNY | 0.0% |
| 2003 FY | -52.43 Million CNY | -3.94% |
| 2002 FY | -50.44 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| C.Q. Pharmaceutical Holding Co., Ltd. | 11.05 Billion CNY | 68.459% |
| Aier Eye Hospital Group Co., Ltd. | -499.02 Million CNY | 798.918% |